Over‐expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Pathology

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.2250PMID 17940995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Pancreaticoduodenectomy for cancer of the head of the pancreas].

  2008cited by this paper
• Twist, a novel oncogene, is upregulated in pancreatic cancer: Clinical implication of Twist expression in pancreatic juice

  2007cited by this paper
• Different Patterns of p16INK4A and p53 Protein Expressions in Intraductal Papillary-Mucinous Neoplasms and Pancreatic Intraepithelial Neoplasia

  2007cited by this paper
• S100A6 Is Increased in a Stepwise Manner during Pancreatic Carcinogenesis: Clinical Value of Expression Analysis in 98 Pancreatic Juice Samples

  2007cited by this paper
• Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer

  2006cited by this paper
• S100A11, A Putative Tumor Suppressor Gene, Is Overexpressed in Pancreatic Carcinogenesis

  2006cited by this paper
• Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice

  2006cited by this paper
• Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization

  2005cited by this paper
• Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer

  2005cited by this paper
• High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.

  2005cited by this paper
• Differential expression of S100A2 and S100A4 in lung adenocarcinomas: Clinicopathological significance, relationship to p53 and identification of their target genes

  2005cited by this paper
• The Role of S100A6 in Pancreatic Cancer Development and Its Clinical Implication as a Diagnostic Marker and Therapeutic Target

  2005cited by this paper
• Brief communication: a new combination in the treatment of advanced pancreatic cancer.

  2005cited by this paper
• A new molecular biology approach in morphology: basic method and application of laser microdissection

  2004cited by this paper
• Proliferative activity in pancreatic intraepithelial neoplasias of chronic pancreatitis resection specimens: detection of a high-risk lesion.

  2004cited by this paper
• Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions.

  2004cited by this paper
• S100 Family Members and Trypsinogens Are Predictors of Distant Metastasis and Survival in Early-Stage Non-Small Cell Lung Cancer

  2004cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts

  2003cited by this paper
• Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.

  2003cited by this paper
• A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform

  2003cited by this paper
• p16 Inactivation in Pancreatic Intraepithelial Neoplasias (PanINs) Arising in Patients With Chronic Pancreatitis

  2003cited by this paper
• Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.

  2003cited by this paper
• Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.

  2002cited by this paper
• Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

  2002cited by this paper
• Gastric cancers overexpress S100A calcium-binding proteins.

  2002cited by this paper
• Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma

  2002cited by this paper
• Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

  2001cited by this paper
• Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.

  2001cited by this paper
• Coordinately up-regulated genes in ovarian cancer.

  2001cited by this paper
• ANALYTICAL BIOCHEMISTRY

  2001cited by this paper
• Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins.

  2001cited by this paper
• S100A2, a Putative Tumor Suppressor Gene, Regulates In Vitro Squamous Cell Carcinoma Migration

  2001cited by this paper
• Genetic profile of 22 pancreatic carcinoma cell lines

  2001cited by this paper
• Unlocking the archive – gene expression in paraffin‐embedded tissue

  2001cited by this paper
• Expression of calcium-binding protein S100A2 in breast lesions

  2000cited by this paper
• Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray Analysis

  2000cited by this paper
• Transcriptional activation of the human S100A2 promoter by wild‐type p53

  1999cited by this paper
• Localization of Ca2+-binding S100 proteins in epithelial tumours of the skin

  1998cited by this paper
• Inactivation of the p53 tumor suppressor gene via a novel Alu rearrangement.

  1998cited by this paper
• The risk of pancreatic cancer following pancreatitis: an association due to confounding?

  1997cited by this paper
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

  1997cited by this paper
• Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients

  1995cited by this paper
• Expression of Ca2+‐binding proteins of the S100 family in malignant human breast‐cancer cell lines and biopsy samples

  1994cited by this paper
• Pancreatitis and the risk of pancreatic cancer.

  1993cited by this paper
• Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper

• Deciphering the senescence‐based tumoral heterogeneity and characteristics in pancreatic cancer: Results from parallel bulk and single‐cell transcriptome data

  2025influential citation
• S100 protein family: Emerging role and mechanism in digestive tract cancer (Review).

  2024cites this paper
• Neoadjuvant chemo‐ or chemo‐radiation‐therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass

  2024cites this paper
• Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset

  2024cites this paper
• Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas

  2024cites this paper
• Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer

  2024cites this paper
• The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma.

  2023cites this paper
• S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors

  2023cites this paper
• S100A2 induces epithelial–mesenchymal transition and metastasis in pancreatic cancer by coordinating transforming growth factor β signaling in SMAD4-dependent manner

  2023cites this paper
• Expansion of a Synthesized Library of N‐Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic Cancer

  2023cites this paper
• Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer.

  2023cites this paper
• Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• C9orf16 represents the aberrant genetic programs and drives the progression of PDAC

  2022cites this paper
• Ca2+ Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma

  2021cites this paper
• The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases

  2021cites this paper
• Targeting the S100A2‐p53 Interaction with a Series of 3,5‐Bis(trifluoromethyl)benzene Sulfonamides: Synthesis and Cytotoxicity

  2021cites this paper
• Prognostic values and immune suppression of the S100A family in pancreatic cancer

  2021cites this paper
• Comprehensive analysis of the prognosis of S100 family members and their relationship with tumor-infiltrating immune cells in human pancreatic adenocarcinoma

  2021cites this paper
• The interaction between S100A2 and KPNA2 mediates NFYA nuclear import and is a novel therapeutic target for colorectal cancer metastasis

  2021cites this paper
• Expressional and Prognostic Value of S100A16 in Pancreatic Cancer Via Integrated Bioinformatics Analyses

  2021cites this paper
• Comprehensive Analysis of the Prognosis of S100 Family Members and Their Relationship with Tumor-In�ltrating Immune Cells in Human Pancreatic Adenocarcinoma

  2021cites this paper
• Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO

  2021cites this paper
• S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives

  2021influential citation
• Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.

  2020cites this paper
• Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer

  2020cites this paper
• Friend or Foe: S100 Proteins in Cancer

  2020cites this paper
• Expression profile and functional role of S100A14 in human cancer

  2019cites this paper
• Connections between the cell cycle, cell adhesion and the cytoskeleton

  2019cites this paper
• Prognostic values of S100 family members in ovarian cancer patients

  2018cites this paper
• Pancreatic cystic tumors: an update

  2018cites this paper
• Regulation and function of S100 proteins in pancreatic carcinoma

  2017cites this paper
• Calcium-binding protein S100A14 induces differentiation and suppresses metastasis in gastric cancer

  2017cites this paper
• Defining post-operative pancreatitis as a new pancreatic specific complication following pancreatic resection.

  2016cites this paper
• Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma.

  2016cites this paper
• CacyBP/SIP--Structure and variety of functions.

  2016cites this paper
• A Salivary Calcium Binding Protein in Patients with Oral Squamous Cell Carcinoma in Relation to Smoking

  2016cites this paper
• Epigenetic silencing of S100A2 in bladder and head and neck cancers

  2015cites this paper
• Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients

  2015cites this paper
• Prognostic and Predictive Protein Biomarkers in Laryngeal Squamous Cell Carcinoma—A Systematic Review

  2015cites this paper
• S100 protein family in human cancer.

  2014cites this paper
• S100 family signaling network and related proteins in pancreatic cancer (Review).

  2014cites this paper
• Clinical significance of S100A2 expression in gastric cancer

  2014cites this paper
• Review Article S100 protein family in human cancer

  2014cites this paper
• S100A14: Novel Modulator of Terminal Differentiation in Esophageal Cancer

  2013cites this paper
• Clinicopathological significance of S100 protein expression in cholangiocarcinoma

  2013cites this paper
• Clinical significance of altered S100A2 expression in gastric cancer.

  2013cites this paper
• Chromatin , Gene , and RNA Regulation S 100 A 14 : Novel Modulator of Terminal Differentiation in Esophageal Cancer

  2013cites this paper
• Pancreatic Cancer: Clinical Significance of Biomarkers

  2013cites this paper
• Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis.

  2013cites this paper
• S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.

  2013cites this paper
• Molecular and proteomic analysis of signaling pathways in pancreatic ductal adenocarcinoma using genetically engineered mouse models

  2012cites this paper
• Intraductal Papillary Mucinous Neoplasm of the Pancreas: An Update

  2012cites this paper
• S100A2 (S100 calcium binding protein A2)

  2012cites this paper
• Intraductal tubulopapillary neoplasm of pancreas with stromal osseous and cartilaginous metaplasia; a case report

  2012cites this paper
• Adjuvant therapy of pancreatic cancer.

  2012cites this paper
• S100A2 in cancerogenesis: a friend or a foe?

  2011cites this paper
• S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma

  2011cites this paper
• Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.

  2011cites this paper
• MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion

  2010cites this paper
• Molecular analysis-based diagnosis for pancreatic cancer and its clinical implication

  2010cites this paper
• Large-scale proteomic identification of S100 proteins in breast cancer tissues

  2010cites this paper
• S100A4 mRNA is a Diagnostic and Prognostic Marker in Pancreatic Carcinoma

  2009cites this paper
• S100A8/A9 Proteins in Diseases of the Exocrine Pancreas

  2009cites this paper
• Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.

  2009cites this paper
• Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma.

  2009cites this paper
• Enhanced Interferon Signaling Pathway in Oral Cancer Revealed by Quantitative Proteome Analysis of Microdissected Specimens Using 16O/18O Labeling and Integrated Two-dimensional LC-ESI-MALDI Tandem MS*

  2009cites this paper
• S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility

  2009cites this paper
• S100A2 Induces Metastasis in Non–Small Cell Lung Cancer

  2009cites this paper
• Caveolin-1: a marker for pancreatic cancer diagnosis

  2008cites this paper
• PROTEOMIC ANALYSIS OF DNA DAMAGE INDUCED STRESS SIGNALING WITH FOCUS ON P 53

  2008cites this paper
• Proteomic analysis of DNA damage induced stress signaling with focus on p53 : S100A6 regulation, function and potential as biomarker in lung cancer and as a novel therapeutic target

  2008cites this paper
• Prognostic significance of AGR 2 in pancreatic ductal adenocarcinoma

  year unknowncites this paper